Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/5655
THE SITUATION OF HEPATOSPLENIC SCHISTOSOMIASIS IN BRAZIL TODAY.
Hepatopatias Parasitárias/parasitologia
Esquistossomose/epidemiologia
Esplenopatias/epidemiologia
Esplenopatias/parasitologia
Brasil/epidemiologia
Humanos
Incidência
Hepatopatias Parasitárias/quimioterapia
Prevalência
Esquistossomose/quimioterapia
Esplenopatias/quimioterapia
Andrade, Zilton de Araújo | Date Issued:
1998
Author
Affilliation
Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil
Abstract
Specific chemotherapy against schistosomiasis together with environmental changes occurring in endemic areas of Brazil are causing a revolution in the clinico-pathological presentation of the disease when comparing to date from 10 to 15 years ago. To update the subject, an inquiry was made among the most experienced Brazilian investigators in this field. They agree that a decrease of about 50 to 70% in prevalence, and an even higher decrease in incidence are taking place in Brazil today. The prevalence of schistosome-infection has decreased in some areas and increased in other, with spreading sometimes occurring to peri-urban regions, indicating that schistosomiasis control depends on the application of multiple measures. General clinical and pathological manifestations related to hepatosplenic disease, such as ascites, gastric hemorrhages, big-spleen syndrome, cor pulmonale, glomerulopathy, etc. are also less severe nowadays than they used to be in the past.
DeCS
Hepatopatias Parasitárias/epidemiologiaHepatopatias Parasitárias/parasitologia
Esquistossomose/epidemiologia
Esplenopatias/epidemiologia
Esplenopatias/parasitologia
Brasil/epidemiologia
Humanos
Incidência
Hepatopatias Parasitárias/quimioterapia
Prevalência
Esquistossomose/quimioterapia
Esplenopatias/quimioterapia
Share